SCHEMBL4354221

SCHEMBL4354221

O=C(Nc1ccc(C(F)(F)F)cc1)N(S)c1cc(Cl)cc(Cl)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 1/20 0.46
P2RX4 Q99571 1/20 0.46
P2RX7 Q99572 1/20 0.46
TMPRSS4 Q9NRS4 1/20 0.46
EPHX2 P34913 1/20 0.43
STK39 Q9UEW8 3/20 0.42
AR P10275 1/20 0.41
GRIK1 P39086 1/20 0.41
CNR2 P34972 1/20 0.41
KCNJ5 P48544 1/20 0.41
KCNJ3 P48549 1/20 0.41
BAZ1A Q9NRL2 1/20 0.40
PTGS1 P23219 1/20 0.40
TBXAS1 P24557 1/20 0.40
MAPK1 P28482 1/20 0.40
PTGS2 P35354 1/20 0.40
MAPK14 Q16539 1/20 0.40
RHOC P08134 1/20 0.40
RHOA P61586 1/20 0.40
JAK2 O60674 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4353445 0.87 TSHR (0.47) P2RX1EPHX2STK39PTGS1TBXAS1
SCHEMBL4341759 0.84 P2RX1 (0.41) P2RX1P2RX4P2RX7TMPRSS4EPHX2
SCHEMBL4353671 0.84 P2RX1 (0.49) P2RX1P2RX4P2RX7TMPRSS4EPHX2
SCHEMBL4353933 0.84 TMPRSS4 (0.60) P2RX1P2RX4P2RX7TMPRSS4EPHX2
SCHEMBL4359460 0.84 EPHX2 (0.46) P2RX1P2RX4P2RX7TMPRSS4EPHX2
SCHEMBL4346853 0.83 STK39 (0.51) STK39PTGS1TBXAS1MAPK1PTGS2
SCHEMBL4347869 0.82 MTOR (0.43) P2RX1P2RX4P2RX7TMPRSS4EPHX2
SCHEMBL4351483 0.82 MTOR (0.42) P2RX1TMPRSS4CNR2MAPK14
SCHEMBL4346893 0.82 PTGS1 (0.41) P2RX1P2RX4P2RX7TMPRSS4STK39
SCHEMBL4347517 0.79 GRIK1 (0.45) STK39GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 P2RX1 2577/4885P2RX4 2254/4885P2RX7 3177/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 P2RX1 2600/4885P2RX4 2271/4885P2RX7 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.